gimli
DRREDDY stock AI analysis

DRREDDY Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

DR. REDDY S LABORATORIES is a large-cap stock in Healthcare. This Gimli page shows the latest available DRREDDY price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Price
₹1,377.90
1W return
+0.36%
1M return
+11.75%
3M return
+14.82%
6M return
+3.08%
1Y return
+10.59%
Market cap
₹114,723.24 cr
PE
41.58
PB
2.95
ROE
+7.80%
ROCE
+9.44%
RSI
70.04
Turnover
₹134.34 cr

Why it can matter in screens

Quick Answers

What is the latest DRREDDY stock price?

The latest stored price for DRREDDY is Rs 1,377.90 as of 2026-11-16.

Is DRREDDY above its 50DMA and 200DMA?

DRREDDY is above 50DMA, above 200DMA. The latest 50DMA is 1,245.16 and the latest 200DMA is 1,254.65.

What are DRREDDY PE, ROE and ROCE?

DRREDDY has PE 41.58, ROE +7.80%, and ROCE +9.44% in Gimli's latest available snapshot.

How has DRREDDY performed recently?

DRREDDY has returned +11.75% over 1 month, +14.82% over 3 months, and +10.59% over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

PeriodRevenueEBITDAPATEPS
2026-09-308,670.80 cr1,879.40 cr925.00 cr11.11
2026-06-308,070.50 cr1,215.30 cr443.50 cr5.32
2026-03-317,516.20 cr863.00 cr220.90 cr2.65
2025-12-318,726.80 cr2,158.60 cr1,209.80 cr14.53
2025-09-308,805.10 cr2,430.80 cr1,437.20 crnan
2025-06-308,545.20 cr2,464.20 cr1,417.80 cr17.04
2025-03-318,506.00 cr2,526.20 cr1,593.30 cr19.12
2024-12-318,358.60 cr2,427.90 crn/a16.96

Annual income statement

YearRevenueEBITDAPATEPS
2026-03-3133,593.30 cr7,916.00 cr4,285.00 cr51.48
2025-03-3132,553.50 cr9,667.10 cr5,654.40 cr67.89
2024-03-3127,916.40 cr8,842.20 cr5,568.40 cr67.04
2023-03-3124,587.90 cr7,443.10 cr4,506.70 cr54.29
2022-03-3114,887.20 cr4,508.00 cr1,623.20 crnan

Balance sheet

PeriodAssetsCashDebtEquity
2026-03-3157,934.60 cr1,536.80 cr7,734.10 cr38,045.70 cr
2025-03-3149,298.90 cr1,465.40 cr4,676.60 cr33,716.60 cr
2024-03-3138,751.80 cr710.70 cr2,002.00 cr28,055.00 cr
2023-03-3132,185.40 cr577.90 cr1,347.20 cr23,099.10 cr
2022-03-3129,282.70 cr1,485.20 cr3,384.50 cr19,052.70 cr

Cash flow

PeriodOCFFCFCash change
2026-03-315,675.50 cr1,833.00 crn/a
2025-03-314,642.80 cr1,203.00 crn/a
2024-03-314,543.30 cr1,799.80 crn/a
2023-03-315,887.50 cr4,000.90 crn/a
2022-03-312,810.80 cr905.90 crn/a

Shareholding Trend

PeriodPromoterFII/FPIDIIMFRetailPledge
2026-09-30+26.63%+31.39%+31.88%+14.14%+9.90%+0.00%
2026-06-30+26.64%+32.07%+31.74%+13.16%+9.35%+0.00%
2026-03-31+26.63%+33.08%+30.72%+13.19%+9.33%+0.00%
2025-12-31+26.64%+33.20%+30.44%+13.87%+9.47%+0.00%
2025-09-30+26.64%+35.52%+27.98%+13.31%+9.61%+0.00%
2025-06-30+26.64%+36.36%+26.74%+13.61%+10.00%+0.00%
2025-03-31+26.64%+37.29%+25.62%+12.89%+10.15%+0.00%
2024-12-31+26.64%+40.08%+22.90%+11.14%+10.22%+0.00%
2024-09-30+26.64%+41.75%+21.48%+10.86%+9.97%+0.00%
2024-06-30+26.65%+42.27%+20.73%+10.05%+10.19%+0.00%
2024-03-31+26.65%+44.49%+18.31%+7.96%+10.38%+0.00%
2023-12-31+26.65%+43.96%+18.65%+8.22%+10.57%+0.00%
2023-09-30+26.66%+42.21%+21.04%+8.61%+9.91%+0.00%
2023-06-30+26.69%+39.54%+21.99%+9.31%+11.57%+0.00%
2023-03-31+26.70%+38.55%+23.05%+9.87%+11.48%n/a
2022-12-31+26.70%+37.82%+23.38%+10.94%+11.84%+0.00%
2022-09-30+26.71%+36.34%+24.70%+12.84%+11.99%+0.00%
2022-06-30+26.71%+0.00%+51.05%n/an/an/a
2022-03-31+26.72%+0.00%+49.94%n/an/a+0.00%
2021-12-31+26.72%+0.00%+49.71%n/an/an/a

Industry Peers

SymbolNameMcapPEROE1Y
SUNPHARMASUN PHARMACEUTICAL IND L448,075.81 cr40.781879+14.03%+6.28%
DIVISLABDIVI S LABORATORIES LTD294,139.21 cr87.463339+21.13%+70.16%
TORNTPHARMTORRENT PHARMACEUTICALS L178,438.17 cr85.011038+16.67%+22.43%
APOLLOHOSPAPOLLO HOSPITALS ENTER. L126,113.56 cr53.952325+24.95%+18.20%
LAURUSLABSLAURUS LABS LIMITED119,848.17 cr89.960566+26.71%+122.22%
ZYDUSLIFEZYDUS LIFESCIENCES LTD118,902.46 cr27.636309+15.44%+26.21%
CIPLACIPLA LTD112,647.78 cr39.472630+8.80%-8.98%
MANKINDMANKIND PHARMA LIMITED108,433.48 cr47.905015+14.41%+15.86%

Try these prompts

Related screen ideas

Data snapshot: 2026-11-16. Not investment advice.